Search research articles
Contact Us
Filters
Showing results (11-20 of 361) with videos related to
Page
of 37
Sort By:
Current Opinion in Oncology
|
June 5, 2003
Prostate cancer update
Jonathan Rosenberg, Eric J Small
Seminars in Oncology
|
June 14, 2002
Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response
Eric J Small, Mack Roach
Future Oncology (London, England)
|
June 12, 2019
Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors
Arpita Desai, Eric J Small
Current Urology Reports
|
April 25, 2006
Immunotherapy for prostate cancer
Lawrence Fong, Eric J Small
Cancer Medicine
|
May 2, 2013
Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?
Edward Cha, Eric J Small
Current Opinion in Oncology
|
March 23, 2006
Prostate cancer update: 2005
Charles J Ryan, Eric J Small
Current Opinion in Oncology
|
May 1, 2002
Prostate cancer update
Brian I Rini, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2005
Early versus delayed androgen deprivation for prostate cancer: new fuel for an old debate
Charles J Ryan, Eric J Small
Current Opinion in Supportive and Palliative Care
|
August 8, 2008
Management of hormone refractory prostate cancer
Amy M Lin, Eric J Small
The Oncologist
|
April 4, 2009
Immunotherapeutics in development for prostate cancer
Andrea L Harzstark, Eric J Small
Page
of 37
Search research articles
Search
Showing results (11-20 of 361) with videos related to
Sort By:
Page
of 37
Current Opinion in Oncology
|
June 5, 2003
Prostate cancer update
Jonathan Rosenberg, Eric J Small
Seminars in Oncology
|
June 14, 2002
Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response
Eric J Small, Mack Roach
Future Oncology (London, England)
|
June 12, 2019
Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors
Arpita Desai, Eric J Small
Current Urology Reports
|
April 25, 2006
Immunotherapy for prostate cancer
Lawrence Fong, Eric J Small
Cancer Medicine
|
May 2, 2013
Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?
Edward Cha, Eric J Small
Current Opinion in Oncology
|
March 23, 2006
Prostate cancer update: 2005
Charles J Ryan, Eric J Small
Current Opinion in Oncology
|
May 1, 2002
Prostate cancer update
Brian I Rini, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2005
Early versus delayed androgen deprivation for prostate cancer: new fuel for an old debate
Charles J Ryan, Eric J Small
Current Opinion in Supportive and Palliative Care
|
August 8, 2008
Management of hormone refractory prostate cancer
Amy M Lin, Eric J Small
The Oncologist
|
April 4, 2009
Immunotherapeutics in development for prostate cancer
Andrea L Harzstark, Eric J Small
Page
of 37